 Your new post is loading...
 Your new post is loading...
|
Scooped by
Gilbert C FAURE
November 2, 2020 4:59 AM
|
Analysis of saliva samples obtained from 16 patients with Sjögren’s syndrome and 10 sicca controls revealed reduced methylation levels of the H19 locus imprinting control region in the patient grou
|
Scooped by
Gilbert C FAURE
October 31, 2020 1:05 PM
|
Despite recent advances in the treatment of autoimmune and inflammatory diseases, unmet medical needs in some areas still exist. One of the main therapeutic approaches to alleviate dysregulated inflammation has been to target the activity of kinases that regulate production of inflammatory mediators. Small-molecule kinase inhibitors have the potential for broad efficacy, convenience and tissue penetrance, and thus often offer important advantages over biologics. However, designing kinase inhibitors with target selectivity and minimal off-target effects can be challenging. Nevertheless, immense progress has been made in advancing kinase inhibitors with desirable drug-like properties into the clinic, including inhibitors of JAKs, IRAK4, RIPKs, BTK, SYK and TPL2. This Review will address the latest discoveries around kinase inhibitors with an emphasis on clinically validated autoimmunity and inflammatory pathways. Unmet medical needs in the treatment of autoimmune and inflammatory diseases still exist. This Review discusses the activity of kinases that regulate production of inflammatory mediators and the recent advances in developing inhibitors to target such kinases.
|
Scooped by
Gilbert C FAURE
October 24, 2020 2:19 PM
|
Objective Anti–topoisomerase I (anti–topo I) autoantibodies in systemic sclerosis (SSc) are associated with diffuse skin involvement and interstitial lung fibrosis. Thus far, however, the relations...
|
Scooped by
Gilbert C FAURE
October 16, 2020 2:14 PM
|
Your pancreas is studded with cell clusters called islets. In most people, special beta cells live snug in the islets, happily making the insulin that the body uses to regulate blood sugar. But in people with type 1 diabetes, the body's T cells mistakenly move into the islets and kill the beta...
|
Scooped by
Gilbert C FAURE
October 8, 2020 4:01 AM
|
Latest Medical News & Articles...
|
Scooped by
Gilbert C FAURE
October 7, 2020 2:52 PM
|
To the Editor, Recently in the Journal of Thrombosis and Haemostasis, Harzallah and colleagues report the results of antiphospholipid antibody testing in a series of 56 patients with confirmed or suspected SARS‐CoV‐2 infection. 1 Twenty‐five patients were found to be positive for lupus anticoagulants, while five patients had either anticardiolipin or anti–β2‐glycoprotein 1 antibodies. The isotypes for the anticardiolipin and anti–β2‐glycoprotein 1 antibodies were reportedly IgG and IgM, although specific antibody titers and details of which were found in combination with a lupus anticoagulant in three overlap patients were not reported. The authors also reference published work by Zhang and colleagues, who reported three patients with SARS‐CoV‐2 infection, coagulopathy, thrombocytopenia, and the presence of anticardiolipin IgA and anti–β2‐glycoprotein 1 IgA and IgG antibodies who developed cerebral infarcts. 2 Harzallah and colleagues suggest the presence of these antibodies should be used as evidence for early anticoagulation of patients with COVID‐19. Antiphospholipid antibodies are common in the general population, especially during infection. 3 , 4 Whether the IgA isotype alone, noted by Zhang and colleagues, invokes thrombosis remains controversial, with only high titer IgG and IgM isotypes included as diagnostic criteria for the antiphospholipid syndrome. 5 Lack of IgG and/or IgM titers in these case series precludes any evaluation of their role in the thrombotic sequelae described. Thrombosis is common during critical illness and all patients in the Zhang series had preexisting cardiovascular disease, further increasing risk for arterial thrombosis. A key question remains whether COVID‐19 patients experience arterial thrombotic events at a higher rate compared to critically ill patients without SARS‐CoV‐2. The findings presented by Zhang and colleagues cannot confirm anticardiolipin antibodies as the causal agent for the arterial thrombosis observed in their series. False positive lupus anticoagulant testing might be expected in patients with COVID‐19 given the marked elevation in measured C‐reactive protein (CRP) levels seen in patients with significant pulmonary or systemic inflammation. Many assays to detect lupus anticoagulants are sensitive to the presence of CRP, resulting in false positive results, further limiting interpretation of this test in the acute inflammatory state. 6 COVID‐19 appears to induce a hypercoagulable state, with elevated fibrinogen, and minimal prolongation of prothrombin time and activated partial thromboplastin time, as seen in these patients. The exact mechanisms underlying the coagulopathy are unclear. 7 We urge clinicians who are evaluating coagulation parameters in patients with COVID‐19 to be cognizant of the pre‐analytic and analytic variables that affect the validity and interpretation of coagulation testing and to adhere to established anticoagulation protocols and guidelines until clinical studies demonstrating efficacy and safety of various anticoagulation strategies are published.
|
Suggested by
Société Francaise d'Immunologie
September 29, 2020 11:43 AM
|
The ease and minimal cost of FR3AK-seq removes critical barriers to routine, large-scale TCR CDR3 repertoire analyses, thereby democratizing the quantitative assessment of human TCR repertoires in disease-relevant target tissues.
|
Scooped by
Gilbert C FAURE
September 24, 2020 4:58 AM
|
Abstract Autoimmune optic neuritis (AON), a model of multiple sclerosis‐associated optic neuritis, is accompanied by degeneration of retinal ganglion cells (RGCs) and optic nerve demyelination and ...
|
Scooped by
Gilbert C FAURE
September 18, 2020 2:49 PM
|
Clarity and guidance is required with regard to the use of direct oral anticoagulants in antiphospholipid syndrome (APS) patients, within the confines of the recent European Medicines Agenc
|
Scooped by
Gilbert C FAURE
September 7, 2020 5:05 AM
|
Abstract Regulatory T (Treg) cells are responsible for maintaining immune homeostasis and preventing autoimmunity. In immune homeostasis condition, Tregs exert their suppressive function through in...
|
Scooped by
Gilbert C FAURE
August 27, 2020 7:41 AM
|
Antiphospholipid syndrome (APS) is a prothrombotic condition characterized by recurrent vascular thrombosis and/or pregnancy morbidity in the presence of circulating antiphospholipid antibodies. Central nervous system (CNS) involvement is a prominent ...
|
Scooped by
Gilbert C FAURE
August 4, 2020 11:28 AM
|
The longtime Johns Hopkins faculty member, known as the father of autoimmune disease research, held appointments in the schools of Medicine and Public Health...
|
Scooped by
Gilbert C FAURE
July 31, 2020 1:35 PM
|
|
|
Scooped by
Gilbert C FAURE
November 1, 2020 7:37 AM
|
Immune-mediated necrotizing myopathy (IMNM) is a group of inflammatory myopathies that was distinguished from polymyositis in 2004. Most IMNMs are associated with anti-signal recognition particle (anti-SRP) or anti-3-hydroxy-3-methylglutaryl-coA reductase (anti-HMGCR) myositis-specific autoantibodies, although ~20% of patients with IMNM remain seronegative. These associations have led to three subclasses of IMNM: anti-SRP-positive IMNM, anti-HMGCR-positive IMNM and seronegative IMNM. IMNMs are frequently rapidly progressive and severe, displaying high serum creatine kinase levels, and failure to treat IMNMs effectively may lead to severe muscle impairment. In patients with seronegative IMNM, disease can be concomitant with cancer. Research into IMNM pathogenesis has shown that anti-SRP and anti-HMGCR autoantibodies cause weakness and myofibre necrosis in mice, suggesting that, as well as being diagnostic biomarkers of IMNM, they may play a key role in disease pathogenesis. Therapeutically, treatments such as rituximab or intravenous immunoglobulins can now be discussed for IMNM, and targeted therapies, such as anticomplement therapeutics, may be a future option for patients with refractory disease. The association of immune-mediated necrotizing myopathy (IMNM) with myositis-specific autoantibodies has led to the classification of three subclasses of IMNM and provided insight into the pathogenesis of, and treatment options for, these inflammatory myopathies.
|
Scooped by
Gilbert C FAURE
October 30, 2020 10:07 AM
|
Psoriasis is a chronically relapsing skin inflammation affecting about 2% the population worldwide. Plaque psoriasis, also known as psoriasis vulgaris, is the most common form of the disease. However there is now accumulating evidence of important systemic manifestations of psoriasis including cardiovascular disorders and metabolic syndrome. About 30% of patients also develop psoriatic arthritis (PsA), which manifests as an inflammation of the synovium, entheses and spine. Therefore, the term Psoriatic Disease has been recently introduced to encompass the different clinical manifestations of this disorder.At the skin level, psoriasis pathogenesis involves a complex interplay between T cells, dendritic cells and keratinocytes in which autoreactive CD8+ T lymphocytes have been suggested to be involved in the early phase, whereas IL-17-producing T cells play a central role in the amplification phase by enhancing the inflammatory response of keratinocytes and creating a positive feedback loop around the IL-23/IL-17 axis. A marked enhancement of IFNγ and Th1 T cell infiltration also occurs in psoriatic plaques, although the specific role of this infiltration in the pathogenesis of psoriasis is currently unclear.Despite our progress in understanding the pathogenesis of plaque psoriasis, the immune mechanisms involved in the development of systemic disease manifestations and psoriatic arthritis remain poorly understood. As an explanation for the development of extra-cutaneou
|
Scooped by
Gilbert C FAURE
October 16, 2020 3:29 PM
|
Sjögren's syndrome is a lymphoproliferative disease with autoimmune features characterized by mononuclear cell infiltration of exocrine glands, notably the lacrimal and salivary glands. These lymphoid infiltrations lead to dryness of the eyes ...
|
Scooped by
Gilbert C FAURE
October 10, 2020 2:07 PM
|
To systematically review and assess the efficacy and safety of hydroxychloroquine (HCQ) for treating primary Sjogren’s syndrome (pSS). Five electronic databases (Pubmed, EMBASE, Web of science, Ovid, Cochrane Library) were searched for randomized controlled trials and retrospective or prospective...
|
Scooped by
Gilbert C FAURE
October 8, 2020 3:57 AM
|
Therapeutic targeting of immune checkpoints has garnered significant attention in the area of cancer immunotherapy, in which efforts have focused in particular on cytotoxic T lymphocyte antigen 4 (CTLA4) and PD1, both of which are members of the CD28 family.
|
Scooped by
Gilbert C FAURE
October 6, 2020 5:03 AM
|
Transancestral mapping and genetic load in systemic lupus erythematosus
|
Scooped by
Gilbert C FAURE
September 25, 2020 2:12 PM
|
Granulomatosis with polyangiitis (GPA) is a severe autoimmune vasculitis associated with the presence of anti-neutrophil cytoplasmic antibodies (ANCA) mainly targeting proteinase 3 (PR3), a neutrophilic serine proteinase. PR3-ANCA binding to membrane-bound PR3 on neutrophils induce their auto-immune activation responsible for vascular lesions. However, the correlation between PR3-ANCA level and disease activity remains inconsistent, suggesting the existence of non-pathogenic PR3-ANCA. In order to prove their existence, we immortalized B lymphocytes from blood samples of GPA patients in remission having persistent PR3-ANCA to isolate non-activating PR3-ANCA. We obtained for the first time a non-activating human IgG1κ anti-PR3 monoclonal antibody (mAb) named 4C3. This new mAb binds soluble PR3 with a high affinity and membrane-bound PR3 on an epitope close to the PR3 hydrophobic patch and in the vicinity of the active site. 4C3 is able to bind FcγRIIA and FcγRIIIB and has a G2F glycosylation profile on asparagine 297. 4C3 did not induce activation of neutrophils and could inhibit human polyclonal PR3-ANCA-induced activation suggesting that 4C3 is non-pathogenic. This characteristic relies on the recognized epitope on PR3 rather than to the Fc portion properties. The existence of non-pathogenic PR3-ANCA, which do not activate neutrophils, could explain the persistence of high PR3-ANCA levels in some GPA patients in remission and why PR3-ANCA would not predict relapse
|
Scooped by
Gilbert C FAURE
September 24, 2020 3:25 AM
|
Autoimmune Addison’s disease (AAD), or primary adrenocortical insufficiency, is a classical organ‐specific autoimmune disease with 160 years of history. AAD is remarkably homogeneous with one major dominant self‐antigen, the cytochrome ...
|
Scooped by
Gilbert C FAURE
September 16, 2020 3:12 AM
|
|
Scooped by
Gilbert C FAURE
September 6, 2020 4:03 AM
|
Systemic lupus erythematosus is a multisystem autoimmune disease that commonly affects the kidneys. Lupus nephritis (LN) is the most common cause of kidney injury in systemic lupus erythematosus and a major risk factor for morbidity and mortality. The pathophysiology of LN is heterogeneous. Genetic and environmental factors likely contribute to this heterogeneity. Despite improved understanding of the pathogenesis of LN, treatment advances have been few and risk for kidney failure remains unacceptably high.
|
Scooped by
Gilbert C FAURE
August 11, 2020 9:40 AM
|
Click on the article title to read more.
|
Scooped by
Gilbert C FAURE
August 4, 2020 11:23 AM
|
High-throughput sequencing and genome-wide association studies have revealed a sex bias in human diseases. The underlying molecular mechanisms remain, however, unknown. Here, we cover recent advances in cancer and autoimmunity focusing on intrinsic genetic and epigenetic differences underlying sex biases in human disease. These studies reveal a central role of genome regulatory mechanisms including genome repair, chromosome folding, and epigenetic regulation in dictating the sex bias. These highlight the importance of considering sex as a variable in both basic science and clinical investigations.
|